e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Biology of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Macrophage immunophenotypic and monocyte activation markers in the immune response in lung cancer
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
Source:
International Congress 2019 – Biology of lung cancer
Session:
Biology of lung cancer
Session type:
Poster Discussion
Number:
3658
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland). Macrophage immunophenotypic and monocyte activation markers in the immune response in lung cancer. 3658
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Monocyte chemotactic protein-1 stimulates lung cancer cells proliferation
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007
Chemokines induced in human lung epithelial cells by inflammatory cytokines
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 332s
Year: 2005
GM-CSF and CSF-1 co-regulate lung inflammation and ERMP12
+
progenitor recruitment during immune responses to LPS
in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 300s
Year: 2006
Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003
Interactions between neutrophils and NSCLC cells in vitro – effects on neutrophil inflammatory mediator generation and tumor cell proliferation
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
CD163 and CCR7 markers for macrophage polarisation in patients with lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Epithelial cell matrix proteins and lymphocyte activation genes in COPD and lung cancer
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Lung cancer immune cells exhibit inhibited inflammasome response
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer
Source: Eur Respir J 2007; 30: 627-632
Year: 2007
Influence of tumour cell lysate on state of lymphocytes‘ activation after DCs stimulation in lung cancer
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
Distinct immune regulatory receptor profiles linked to altered monocyte subsets in sarcoidosis
Source: ERJ Open Res, 7 (1) 00804-2020; 10.1183/23120541.00804-2020
Year: 2021
Chemokine receptor expression and function of infiltrated neutrophils in inflammatory lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 856s
Year: 2006
Monocyte sub-populations do not reflect differences in COPD macrophage phenotype
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept